Quick Takeaways: Why It Matters? Petwealth’s partnership with Kennel Connection aims to embed molecular (PCR) health screening directly into boarding, daycare, grooming and training facilities- places pets already visit regularly- so owners get earlier, actionable hea...
Quick Takeaways: Why It Matters? By putting TRUFORMA analyzers in equine clinics at no cost and offering free PPID testing cartridges to eligible Boehringer Ingelheim customers, the program makes it much easier and faster for vets to diagnose and monitor Cus...
Quick Takeaways: Why It Matters? IDEXX’s Catalyst proBNP brings a well‑known heart‑disease blood test into the vet clinic with results in minutes, so vets can spot hidden heart problems, decide quickly in breathing emergencies, and monitor patients without waiting day...
Quick Takeaways: Why It Matters? Boehringer Ingelheim’s purchase of Evax gives it a promising new way to treat common horse allergies with longer‑lasting vaccines instead of short‑term symptom relief, which could mean fewer vet visits and better outcomes for owners. If the approach works a...
Quick Takeaways: Why It Matters? The launch should help Zomedica make PulseVet easier to use in everyday practice by improving patient and staff comfort, potentially reducing anxiety-driven resistance and making clinics more willing to adopt or keep using shock wave therapy for equine and ...
Quick Takeaways: Why It Matters? By terminating the PrecisePRP arrangement with VetStem, PetVivo removes outstanding invoices, royalties and milestone overhangs from a non-core product line, which should simplify the story for investors and management while freeing attention and capital fo...
Quick Takeaways: Why It Matters? LIMPID’s acquisition of PetPeotalk turns Kinfora into a richer, behaviour‑driven pet health platform, because it brings in a mature vision‑AI stack (Dogibogi) with real‑world scale, hundreds of millions of labelled behaviour ...
Quick Takeaways: Why It Matters? Full FDA approval for Laverdia transforms it from a conditionally approved option into the first fully approved oral, at‑home standard therapy for canine lymphoma, which should significantly boost veterinarian confidence and utilization via Dechra’s nationa...
Quick Takeaways: Why It Matters? Elanco Ventures adds a structured, early-stage venture arm to Elanco’s strategy, giving the company a dedicated channel to access and co-develop emerging animal health technologies before they become mature competitors or acquisition targets. The ...
Quick Takeaways: Why It Matters? Pawsible Ventures is positioning itself as the “infrastructure VC” for pet health, and this eight‑company debut cohort shows what that means in practice: e‑prescribing rails (VetHubRx), AI clinic copilots (NxVET, PupPilot), preventive‑...
